← Back to patent-cliff list
盐酸卡替洛尔
Tier C — Watch / tradeCarteolol Hydrochloride
艾伯维
Originator
1980
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ADRB2、ADRB1
Brand：Mikelan LA、Mikelan、Arteolol、Carteol、Arteoptic、Teoptic、Cartrol、Ocupress
Indications (approved)：高血压、高眼压、青光眼、心绞痛、心律失常
Regional status
US
-
EU
-
China
批准上市
1995-01-01
Japan
批准上市
1980-10-25
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Carteolol Hydrochloride?
Approved indications include: 高血压, 高眼压, 青光眼, 心绞痛, 心律失常.
When does the Carteolol Hydrochloride patent expire?
No public expiry year is available for Carteolol Hydrochloride yet; this page updates once verified.
How do I get a quote for Carteolol Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25